Product Information
URO-MP CAPSULE is a generic product labeled by Method Pharmaceuticals LLC, priced at $1.7946 per EA under NDC 58657045601. Its NADAC has been published 311 times since Oct 21, 2020.
URO-MP CAPSULE
Methenamine, Sodium Phosphate, Monobasic, Anhydrous, Phenyl Salicylate, Methylene Blue and Hyoscyamine SulfateStrength
.12; 118; 10; 36; 40.8 mg/1; mg/1; mg/1; mg/1; mg/1
Manufacturer
Method Pharmaceuticals LLCNDC
58657045601
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
HYOSCYAMINE SULFATE; METHENAMINE; METHYLENE BLUE; PHENYL SALICYLATE; SODIUM PHOSPHATE, MONOBASIC, ANHYDROUSApproval Type
Unapproved
On Market Since
12/1/2014
Pharmacological Classes
Price Statistics
The NADAC for URO-MP CAPSULE has been published 311 times since Oct 21, 2020, and over the history we have for it it has risen 2.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.7946 per EA |
|---|---|
| All-time high | $1.9256 (Dec 14, 2022) |
| All-time low | $1.2732 (May 22, 2024) |
| 52-week high | $1.8099 |
| 52-week low | $1.6630 |
| Median price | $1.7037 |
| Average price | $1.6897 |
| Largest weekly change | -21.6% (Apr 17, 2024) |
| Weeks tracked | 311 |
| Tracking since | Oct 21, 2020 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Methenamine, Sodium Phosphate, Monobasic, Anhydrous, Phenyl Salicylate, Methylene Blue and Hyoscyamine Sulfate market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Method Pharmaceuticals LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Methenamine, Sodium Phosphate, Monobasic, Anhydrous, Phenyl Salicylate, Methylene Blue and Hyoscyamine Sulfate market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Osmotic Laxative class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of URO-MP CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for URO-MP CAPSULE, manufactured by Method Pharmaceuticals LLC, is $1.7946 per EA (NDC 58657045601), effective Sep 30, 2026.
How has the price of URO-MP CAPSULE changed over time?
Over the history we have for it, the NADAC for URO-MP CAPSULE has risen 2.5%. It has been tracked across 311 weekly CMS publications since Oct 21, 2020.
What are the highest and lowest recorded NADAC prices for URO-MP CAPSULE?
Since Oct 21, 2020, the NADAC for URO-MP CAPSULE has ranged from a low of $1.2732 (May 22, 2024) to a high of $1.9256 (Dec 14, 2022), with a median of $1.7037 per EA.
Are there cheaper alternatives to URO-MP CAPSULE?
No other NADAC-published product currently shares the active ingredient and strength of URO-MP CAPSULE in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures URO-MP CAPSULE?
URO-MP CAPSULE (NDC 58657045601) is labeled by Method Pharmaceuticals LLC, and CMS classifies it as a generic product.